Jove
Visualize
联系我们

相关概念视频

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

160
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
160
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

182
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
182
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

696
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
696
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

290
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
290
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

145
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
145
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

62
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
62

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Psychedelics action and schizophrenia.

Pharmacological reports : PR·2024
Same author

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.

International journal of molecular sciences·2024
Same author

TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice.

Cellular and molecular life sciences : CMLS·2023
Same author

Epigenetic Targets in Schizophrenia Development and Therapy.

Brain sciences·2023
Same author

Gene Expression and Epigenetic Regulation in the Prefrontal Cortex of Schizophrenia.

Genes·2023
Same author

Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.

International journal of molecular sciences·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K

迷幻药的作用和精神分裂症

Marzena Maćkowiak1

  • 1Laboratory of Pharmacology and Brain Biostructure, Pharmacology Department, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland. mackow@if-pan.krakow.pl.

Pharmacological reports : PR
|October 30, 2023
PubMed
概括
此摘要是机器生成的。

迷幻药,通过血清素5-HT2A受体起作用,显示神经精神疾病的治疗潜力. 然而,它们的精神病效应需要谨慎的剂量或用于治疗精神分裂症的非幻觉类比.

关键词:
5-HT2A受体是一种受体.幻觉制造物 幻觉制造物精神障碍 精神障碍是一种精神障碍.治疗疗法 治疗疗法

更多相关视频

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.5K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.0K

相关实验视频

Last Updated: Jul 12, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.3K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.5K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.0K

科学领域:

  • 神经科学是一个神经科学.
  • 精神病学是一个精神病学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 迷幻药激活了血清素5-HT2A受体,影响了行为,并显示了抑郁症和PTSD的前景.
  • 精神分裂症与迷幻药物共享神经生物学途径,包括受损的血清和葡萄糖系统.
  • 精神分裂症的特征是突触损失,与迷幻药的神经可塑性影响形成鲜明对比.

研究的目的:

  • 探索幻化药在精神分裂症治疗中的潜在治疗应用.
  • 为了研究心理药物和精神分裂症之间共享的神经生物学机制.
  • 解决在精神分裂症治疗中使用迷幻药的挑战和潜在策略.

主要方法:

  • 审查现有的关于迷幻药的作用和精神分裂症症状的研究结果.
  • 分析神经生物学相似性,包括神经递质系统和神经可塑性.
  • 讨论治疗策略,包括剂量和非幻觉类同类药物.

主要成果:

  • 迷幻药物和精神分裂症表现出重叠的神经生物学特征,特别是涉及血清素和谷氨酸的途径.
  • 迷幻药物促进神经可塑性 (协同生成,神经生成),可能抵消精神分裂症中的突触损失.
  • 迷幻药的精神致死效应对精神分裂症治疗构成了挑战,建议采用亚迷幻或微剂量方法.

结论:

  • 迷幻药因其神经可塑性作用而有可能用于精神分裂症治疗,尽管共享与精神病相关的途径.
  • 进一步的研究至关重要,以建立安全有效的剂量方案,可能涉及非幻觉类同类.
  • 需要进行探索性临床前和临床研究,以验证5-HT2A激动剂在治疗精神分裂症方面的疗效.